Caden Capital Partners, LP Becton Dickinson & CO Transaction History

Caden Capital Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $5.89 Million - $6.44 Million	-26,168 Reduced 23.7%	84,241 $19.7 Billion
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $6.3 Million - $6.69 Million	26,992 Added 32.36%	110,409 $27.3 Billion
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $4.09 Million - $4.7 Million	17,599 Added 26.74%	83,417 $20.3 Billion
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $1.59 Million - $1.77 Million	-6,241 Reduced 8.66%	65,818 $17 Billion
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $2.48 Million - $2.76 Million	-10,409 Reduced 12.62%	72,059 $19 Billion
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $11.5 Million - $13 Million	50,090 Added 154.7%	82,468 $20.4 Billion
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $7.07 Million - $8.32 Million	32,378 New	32,378 $8.23 Billion

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Caden Capital Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Caden Capital Partners, LP with notifications on news.